{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:43:46Z","timestamp":1778697826813,"version":"3.51.4"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8,20]]},"DOI":"10.1097\/qad.0b013e328307a029","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T21:47:33Z","timestamp":1236289653000},"page":"1633-1640","source":"Crossref","is-referenced-by-count":35,"title":["Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants"],"prefix":"10.1097","volume":"22","author":[{"given":"Woong Hwan","family":"Bae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Wester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura M","family":"Smeaton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger L","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahin","family":"Lockman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Onyait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibou","family":"Thior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Essex","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-14-20210130","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group","volume":"331","author":"Connor","year":"1994","journal-title":"N Engl J Med"},{"key":"R2-14-20210130","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00042560-200204150-00009","article-title":"Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission","volume":"29","author":"Cooper","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R3-14-20210130","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/QAD.0b013e3280d5a786","article-title":"In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children","volume":"21","author":"Brogly","year":"2007","journal-title":"AIDS"},{"key":"R4-14-20210130","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/507645","article-title":"Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An analysis of the women and infants transmission study","volume":"194","author":"Pacheco","year":"2006","journal-title":"J Infect Dis"},{"key":"R5-14-20210130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jama.281.2.151","article-title":"Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219\/076 Teams","volume":"281","author":"Culnane","year":"1999","journal-title":"JAMA"},{"key":"R6-14-20210130","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00042560-200206010-00010","article-title":"Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants","volume":"30","author":"Mofenson","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R7-14-20210130","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1097\/00002030-200309260-00006","article-title":"Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants","volume":"17","author":"Le Chenadec","year":"2003","journal-title":"AIDS"},{"key":"R8-14-20210130","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1080\/08035250510042951","article-title":"Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers","volume":"94","author":"Bunders","year":"2005","journal-title":"Acta Paediatr"},{"key":"R9-14-20210130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/QAI.0b013e318042d5e3","article-title":"Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants","volume":"45","author":"Feiterna-Sperling","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-14-20210130","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1097\/00002030-200410210-00005","article-title":"Levels and patterns of neutrophil cell counts over the first 8 years of life in children of HIV-1-infected mothers.","volume":"18","year":"2004","journal-title":"AIDS"},{"key":"R11-14-20210130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00002018-200730030-00004","article-title":"Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?","volume":"30","author":"Thorne","year":"2007","journal-title":"Drug Saf"},{"key":"R12-14-20210130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1179\/146532806X120255","article-title":"Within and between race differences in lymphocyte, CD4+, CD8+ and neutrophil levels in HIV-uninfected children with or without HIV exposure in Europe and Uganda","volume":"26","author":"Bunders","year":"2006","journal-title":"Ann Trop Paediatr"},{"key":"R13-14-20210130","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.qai.0000224975.45091.a5","article-title":"Range of normal neutrophil counts in healthy Zimbabwean infants: implications for monitoring antiretroviral drug toxicity","volume":"42","author":"Wells","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R14-14-20210130","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/01.inf.0000168835.01233.64","article-title":"Age-related standards for total lymphocyte, CD4+ and CD8+ T cell counts in children born in Europe","volume":"24","author":"Bunders","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R15-14-20210130","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.aids.0000232236.26630.35","article-title":"Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana","volume":"20","author":"Shapiro","year":"2006","journal-title":"AIDS"},{"key":"R16-14-20210130","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/jama.296.7.794","article-title":"Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study","volume":"296","author":"Thior","year":"2006","journal-title":"JAMA"},{"key":"R19-14-20210130","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/INF.0b013e31812f56ed","article-title":"Maternal antiretrovirals and hepatic enzyme, hematologic abnormalities among human immunodeficiency virus type 1-uninfected infants: the NISDI perinatal study","volume":"26","author":"Mussi-Pinhata","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R20-14-20210130","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00126334-200312150-00006","article-title":"Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months","volume":"34","author":"Shetty","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R21-14-20210130","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1086\/432483","article-title":"Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment","volume":"192","author":"Shapiro","year":"2005","journal-title":"J Infect Dis"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-200808200-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:06:33Z","timestamp":1618038393000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-200808200-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,20]]},"references-count":19,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328307a029","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8,20]]}}}